GenoTwin Inc.
Dohyun Nam has a diverse work experience spanning multiple roles and companies. Dohyun is currently a Co-Founder at GenoTwin Inc. since June 2020 and at AVATAMED since August 2019. Prior to that, they founded and served as the CEO of Aimed Bio Inc. from August 2018. Earlier in their career, they worked at Samsung Medical Center as a Director and Neurosurgeon starting from March 1997. Dohyun also held a position as a Professor at Sungkyunkwan University since 1999.
Dohyun Nam obtained a Doctor of Philosophy - PhD degree in Medicine from Seoul National University, from the year 1997 to 2001.
This person is not in any teams
This person is not in any offices
GenoTwin Inc.
GenoTwin’s core mission is to weave the power of genomics into the public health fabric by providing powerful and practical solutions to the world's pressing infectious disease challenges. Our innovative genomics platform combines cutting-edge capabilities in genomics, AI, and computational biology to support clinicians, public healthofficials, and researchers in four key areas: Pathogen Detection; Pathogen Surveillance; Immune/Resistance Assessment; and Precision Treatment.